High street pharmacy chain Boots has announced that it will begin offering medical cannabis through a new online service, marking a major milestone as a first for a British high street pharmacy. According to The Guardian, the initiative is designed to provide access for patients in the UK aged 25 and older who suffer from eligible health conditions such as chronic pain, anxiety, or insomnia.

The newly introduced service, named SureLeaf, is launching alongside a collaborative research programme with the University of Nottingham. This academic partnership will examine patient outcomes, prescribing practices, and overall experiences in treating chronic pain.
How the Online Prescription Process Works
Patients wishing to use the service must first complete an initial online assessment. Following this, a clinical team will review their suitability before inviting them to a video consultation with a consultant. Boots has emphasised that strict safety protocols are in place.
Any proposed prescription will be independently reviewed by a multidisciplinary clinical team, which must include a second independent consultant before any treatment plan begins. Furthermore, the pharmacy stipulates that patients seeking medical cannabis must have previously tried conventional treatments without achieving adequate symptom relief. Regular ongoing reviews will also be conducted for patients who commence treatment.
Clinical Perspective and Safeguards
Jamie Kerruish, the chief healthcare officer at Boots, highlighted the impact of ongoing conditions on daily life. “Millions of people live with ongoing pain and, for some, conventional treatments do not provide adequate symptom relief,” Kerruish said. “Ultimately, it’s about helping people explore appropriate options that could help them better manage their symptoms and improve their quality of life.”
Dr David Gwynne, medical director of Boots’ online service, added that medical cannabis is not suitable for everyone. He noted that prescriptions require careful, individual evaluation with strong clinical safeguards and specialist oversight at every stage of the treatment process.
Context of Medical Cannabis in the UK
The legal framework for cannabis-derived medicines in the United Kingdom changed in 2018 following high-profile public campaigns. While numerous private clinics have offered these treatments for several years, NHS availability remains tightly restricted, typically limited to rare forms of epilepsy, chemotherapy side-effects, and specific multiple sclerosis symptoms.
Source: Boots to begin prescribing medical cannabis in UK (source-feed timestamp 2026-11-16T10:32:50+00:00). AI-assisted report based on the cited linked article and its RSS feed; details were not independently verified.
Context matters. Read about our editorial standards and corrections policy.



Join the conversation